Capital Research Global Investors Johnson & Johnson Transaction History
Capital Research Global Investors
- $479 Billion
- Q2 2025
A detailed history of Capital Research Global Investors transactions in Johnson & Johnson stock. As of the latest transaction made, Capital Research Global Investors holds 3,387,447 shares of JNJ stock, worth $630 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,387,447
Previous 2,457,417
37.85%
Holding current value
$630 Million
Previous $408 Million
26.97%
% of portfolio
0.11%
Previous 0.09%
Shares
31 transactions
Others Institutions Holding JNJ
# of Institutions
4,656Shares Held
1.77BCall Options Held
18.4MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA237MShares$44.1 Billion0.61% of portfolio
-
Black Rock Inc. New York, NY198MShares$36.9 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$24.7 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA60.6MShares$11.3 Billion0.67% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$10.1 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $486B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...